Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 3/2014

01-12-2014 | Letter to the Editor

Precocious and isolated thyroid metastasis of colorectal adenocarcinoma and incidental thyroid papillary microcarcinoma

Authors: T. Amenduni, A. Carbone, R. Bruno

Published in: Endocrine | Issue 3/2014

Login to get access

Excerpt

Metastases of nonthyroid malignancies to the thyroid gland are found to be a rare occurrence. They have been reported in only 1.4–3 % of all the patients who underwent surgery for suspected cancer in the thyroid gland [1]. …
Literature
1.
G. Papi, G. Fadda, S.M. Corsello, S. Corrado, E.D. Rossi, E. Radighieri, A. Miraglia, C. Carani, A. Pontecorvi, Metastases to thyroid gland: prevalence, clinicopathological aspects and prognosis: a 10-year experience. Clin. Endocrinol. 66, 565–571 (2007)
2.
K. Wood, L. Vini, C. Harmer, Metastases to the thyroid gland: the Royal Marsden experience. Eur. J. Surg. Oncol. 30, 583–588 (2004)PubMedCrossRef
3.
A.Y. Chung, T.B. Tran, K.T. Brumund, R.A. Weisman, M. Bouvet, Metastases to the thyroid: a review of the literature from the last decade. Thyroid 22, 258–268 (2012)PubMedCrossRef
Metadata
Title
Precocious and isolated thyroid metastasis of colorectal adenocarcinoma and incidental thyroid papillary microcarcinoma
Authors
T. Amenduni
A. Carbone
R. Bruno
Publication date
01-12-2014
Publisher
Springer US
Published in
Endocrine / Issue 3/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0258-2

Other articles of this Issue 3/2014

Endocrine 3/2014 Go to the issue

Endocrine Imaging

Concentric-ring sign in adrenal hemorrhage

Original Article

The follicular outcome after standard gonadotropin stimulation is associated with ERα and ERβ genotypes

Original Article

Cushing’s syndrome in type 2 diabetes patients with poor glycemic control

Review

Gastrointestinal hormones and polycystic ovary syndrome

Original Article

Neferine prevented hyperglycemia-induced endothelial cell apoptosis through suppressing ROS/Akt/NF-κB signal

Original Article

Effects of genistein on stereological and hormonal characteristics of the pituitary somatotrophs in rats
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits